ITA9709
ITA9709
- Catalog: ITA9709
- Gene/Protein: TCEAL7
- Product Description: Immunotag™ TCEAL7 Antibody
385.0000
Price in reward points: 385
| Antibody Specification | |
| Datasheet |
|
| Target Protein | TCEAL7 |
| Clonality | Polyclonal |
| Storage/Stability | -20°C/1 year |
| Application | WB,ELISA |
| Recommended Dilution | WB 1:1000-3000 |
| Concentration | 1 mg/ml |
| Reactive Species | Human,Mouse |
| Host Species | Rabbit |
| Immunogen | A synthesized peptide derived from human TCEAL7 |
| Specificity | TCEAL7 Antibody detects endogenous levels of total TCEAL7 |
| Purification | The antiserum was purified by peptide affinity chromatography. |
| Form | Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.Store at -20 °C.Stable for 12 months from date of receipt |
| Gene Name | TCEAL7 |
| Accession No. | Q9BRU2 |
| Alternate Names | 1110018P05Rik; AI118095; LL0XNC01-105G4.1; MPMGp800C04260Q003; RP23-105O4.2; TCAL7_HUMAN; TCEA-like protein 7; TCEAL7; Transcription elongation factor A protein-like 7; Transcription elongation factor S-II protein-like 7; |
| Description | Plays a role in the negative regulation of NF-kappa-B signaling at the basal level by modulating transcriptional activity of NF-kappa-B on its target gene promoters. Associates with cyclin D1 promoter containing Myc E-box sequence and transcriptionally represses cyclin D1 expression. Regulates telomerase reverse transcriptase expression and telomerase activity in both ALT (alternative lengthening of telomeres)and telomerase-positive cell lines. |
| Cell Pathway/ Category | Primary Polyclonal Antibody |
| Protein MW | 12 kDa |
| Usage | For Research Use Only! Not for diagnostic or therapeutic procedures. |
| Material Safety Data Sheet | |
| English_US |
|
| Danish |
|
| Dutch |
|
| English_UK |
|
| French |
|
| German |
|
| Spanish |
|
| Norwegian |
|
| Portuguese |
|
| Finnish |
|
| Swedish |
|
| Polish |
|